Evidence map›Paper›PMID 37783919›Full record

ArticleAAPS PharmSciTech2023

A Novel Oral Drugs Delivery System for Borneol Based on HiCap

Yuan Chen, Xiaowei Jin, Yanhui Kuang, Sisi Zhang, Chuanping Zhang, Chuyuan Li, Bohong Guo

Abstract read
PubMed Publisher
In one paragraph

Article in AAPS PharmSciTech, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yuan ChenDepartment of Pharmaceutics, School of Pharmacy, Guangzhou Higher Education Mega Center, Guangdong Pharmaceutical University, 280 East Waihuan Road, Guangzhou, 510006, China.
Xiaowei JinDepartment of Pharmaceutics, School of Pharmacy, Guangzhou Higher Education Mega Center, Guangdong Pharmaceutical University, 280 East Waihuan Road, Guangzhou, 510006, China.
Yanhui KuangGuangdong Baiyun Mountain and Hutchison Whampoa Ltd., Modern Chinese Medicine Research Institute, Guangzhou, 510515, China.
Sisi ZhangGuangdong Baiyun Mountain and Hutchison Whampoa Ltd., Modern Chinese Medicine Research Institute, Guangzhou, 510515, China.
Chuanping ZhangGuangdong Baiyun Mountain and Hutchison Whampoa Ltd., Modern Chinese Medicine Research Institute, Guangzhou, 510515, China.
Chuyuan LiGuangdong Baiyun Mountain and Hutchison Whampoa Ltd., Modern Chinese Medicine Research Institute, Guangzhou, 510515, China.
Bohong GuoDepartment of Pharmaceutics, School of Pharmacy, Guangzhou Higher Education Mega Center, Guangdong Pharmaceutical University, 280 East Waihuan Road, Guangzhou, 510006, China. guobohong@gdpu.edu.cn.ORCID http://orcid.org/0000-0002-5775-5506
Guangdong Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to create a new method for delivering oral borneol (BN) drug that would improve stability. This was accomplished through microencapsulation using HiCap

Indexed as

Intestinal AbsorptionIntestinesAnimalsATP Binding Cassette Transporter, Subfamily BATP Binding Cassette Transporter, Subfamily B, Member 1CamphanesPolysaccharidesRatsSpectroscopy, Fourier Transform InfraredATP Binding Cassette Transporter, Subfamily BATP Binding Cassette Transporter, Subfamily B, Member 1CamphanesisoborneolmaltodextrinPolysaccharidesabsorption enhancersborneolmicroencapsulationp-glycoproteinsingle-pass intestinal perfusion

Identifiers

PMID37783919
OpenAlexW4387245022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.